Prognostic impact of PD-L1 expression in pN1 NSCLC: a retrospective single-center analysis

Simple Summary - The analysis of prognostic biomarkers (e.g., PD-L1) helps to define treatment for lung cancer patients. To date, these markers have only been examined in metastatic or inoperable situations. We analyzed the PD-L1 expression-levels of tumors from 277 lung cancer patients that underwe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eichhorn, Florian (VerfasserIn) , Kriegsmann, Mark (VerfasserIn) , Klotz, Laura Valentina (VerfasserIn) , Kriegsmann, Katharina (VerfasserIn) , Muley, Thomas (VerfasserIn) , Zgorzelski, Christiane (VerfasserIn) , Christopoulos, Petros (VerfasserIn) , Winter, Hauke (VerfasserIn) , Eichhorn, Martin E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 April 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 9, Pages: 1-13
ISSN:2072-6694
DOI:10.3390/cancers13092046
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13092046
Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122862/
Volltext
Verfasserangaben:Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter and Martin E. Eichhorn

MARC

LEADER 00000caa a2200000 c 4500
001 1761093525
003 DE-627
005 20220820001318.0
007 cr uuu---uuuuu
008 210623s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13092046  |2 doi 
035 |a (DE-627)1761093525 
035 |a (DE-599)KXP1761093525 
035 |a (OCoLC)1341416358 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eichhorn, Florian  |d 1984-  |e VerfasserIn  |0 (DE-588)143005952  |0 (DE-627)641429045  |0 (DE-576)334573483  |4 aut 
245 1 0 |a Prognostic impact of PD-L1 expression in pN1 NSCLC  |b a retrospective single-center analysis  |c Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter and Martin E. Eichhorn 
264 1 |c 23 April 2021 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.06.2021 
520 |a Simple Summary - The analysis of prognostic biomarkers (e.g., PD-L1) helps to define treatment for lung cancer patients. To date, these markers have only been examined in metastatic or inoperable situations. We analyzed the PD-L1 expression-levels of tumors from 277 lung cancer patients that underwent curative intent surgery. PD-L1 was identified as a prognostic factor, depending on histologic subtype. - - Abstract - The programmed death-ligand 1 (PD-L1) plays a crucial role in immunomodulatory treatment concepts for end-stage non-small cell lung cancer (NSCLC). To date, its prognostic significance in patients with curative surgical treatment but regional nodal metastases, reflecting tumor spread beyond the primary site, is unclear. We evaluated the prognostic impact of PD-L1 expression in a surgical cohort of 277 consecutive patients with pN1 NSCLC on a tissue microarray. Patients with PD-L1 staining (clone SP263) on >1% of tumor cells were defined as PD-L1 positive. Tumor-specific survival (TSS) of the entire cohort was 64% at five years. Low tumor stage (p < 0.0001) and adjuvant therapy (p = 0.036) were identified as independent positive prognostic factors in multivariate analysis for TSS. PD-L1 negative patients had a significantly better survival following adjuvant chemotherapy than PD-L1 positive patients. The benefit of adjuvant therapy diminished in patients with PD-L1 expression in more than 10% of tumor cells. Stratification towards histologic subtype identified PD-L1 as a significant positive predictive factor for TSS after adjuvant therapy in patients with adenocarcinoma, but not squamous cell carcinoma. Routine PD-L1 assessment in curative intent treatment may help to identify patients with a better prognosis. Further research is needed to elucidate the predictive value of PD-L1 in an adjuvant setting. 
700 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
700 1 |a Klotz, Laura Valentina  |d 1983-  |e VerfasserIn  |0 (DE-588)143075101  |0 (DE-627)641874685  |0 (DE-576)334894921  |4 aut 
700 1 |a Kriegsmann, Katharina  |d 1986-  |e VerfasserIn  |0 (DE-588)1049422449  |0 (DE-627)781924006  |0 (DE-576)40339774X  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Zgorzelski, Christiane  |e VerfasserIn  |0 (DE-588)1167972317  |0 (DE-627)1031669019  |0 (DE-576)511377622  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Winter, Hauke  |e VerfasserIn  |0 (DE-588)1162076038  |0 (DE-627)1025509773  |0 (DE-576)176791531  |4 aut 
700 1 |a Eichhorn, Martin E.  |d 1974-  |e VerfasserIn  |0 (DE-588)124436900  |0 (DE-627)363346627  |0 (DE-576)294170545  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021), 9, Artikel-ID 2046, Seite 1-13  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Prognostic impact of PD-L1 expression in pN1 NSCLC a retrospective single-center analysis 
773 1 8 |g volume:13  |g year:2021  |g number:9  |g elocationid:2046  |g pages:1-13  |g extent:13  |a Prognostic impact of PD-L1 expression in pN1 NSCLC a retrospective single-center analysis 
856 4 0 |u https://doi.org/10.3390/cancers13092046  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122862/  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210623 
993 |a Article 
994 |a 2021 
998 |g 124436900  |a Eichhorn, Martin E.  |m 124436900:Eichhorn, Martin E.  |d 910000  |d 950000  |d 950900  |e 910000PE124436900  |e 950000PE124436900  |e 950900PE124436900  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 9  |y j 
998 |g 1162076038  |a Winter, Hauke  |m 1162076038:Winter, Hauke  |d 910000  |d 950000  |d 950900  |e 910000PW1162076038  |e 950000PW1162076038  |e 950900PW1162076038  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 8 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 7 
998 |g 1167972317  |a Zgorzelski, Christiane  |m 1167972317:Zgorzelski, Christiane  |d 910000  |d 912000  |e 910000PZ1167972317  |e 912000PZ1167972317  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
998 |g 1049422449  |a Kriegsmann, Katharina  |m 1049422449:Kriegsmann, Katharina  |d 910000  |d 910100  |e 910000PK1049422449  |e 910100PK1049422449  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 143075101  |a Klotz, Laura Valentina  |m 143075101:Klotz, Laura Valentina  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PK143075101  |e 950000PK143075101  |e 950900PK143075101  |e 50000PK143075101  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |d 50000  |e 910000PK103740324X  |e 912000PK103740324X  |e 50000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 2 
998 |g 143005952  |a Eichhorn, Florian  |m 143005952:Eichhorn, Florian  |d 910000  |d 950000  |d 950900  |e 910000PE143005952  |e 950000PE143005952  |e 950900PE143005952  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 1  |x j 
999 |a KXP-PPN1761093525  |e 3940896276 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"13 S."}],"id":{"eki":["1761093525"],"doi":["10.3390/cancers13092046"]},"language":["eng"],"origin":[{"dateIssuedDisp":"23 April 2021","dateIssuedKey":"2021"}],"recId":"1761093525","name":{"displayForm":["Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter and Martin E. Eichhorn"]},"person":[{"display":"Eichhorn, Florian","family":"Eichhorn","given":"Florian","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Mark","family":"Kriegsmann","display":"Kriegsmann, Mark"},{"display":"Klotz, Laura Valentina","family":"Klotz","given":"Laura Valentina","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Katharina","roleDisplay":"VerfasserIn","role":"aut","display":"Kriegsmann, Katharina","family":"Kriegsmann"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Thomas","family":"Muley","display":"Muley, Thomas"},{"display":"Zgorzelski, Christiane","family":"Zgorzelski","given":"Christiane","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Petros","family":"Christopoulos","display":"Christopoulos, Petros"},{"family":"Winter","display":"Winter, Hauke","roleDisplay":"VerfasserIn","role":"aut","given":"Hauke"},{"display":"Eichhorn, Martin E.","family":"Eichhorn","given":"Martin E.","roleDisplay":"VerfasserIn","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"language":["eng"],"id":{"issn":["2072-6694"],"zdb":["2527080-1"],"eki":["614095670"]},"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"recId":"614095670","origin":[{"dateIssuedDisp":"2009-","publisherPlace":"Basel","publisher":"MDPI","dateIssuedKey":"2009"}],"disp":"Prognostic impact of PD-L1 expression in pN1 NSCLC a retrospective single-center analysisCancers","type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2009 -"],"part":{"volume":"13","extent":"13","text":"13(2021), 9, Artikel-ID 2046, Seite 1-13","pages":"1-13","issue":"9","year":"2021"},"title":[{"title":"Cancers","title_sort":"Cancers"}],"note":["Gesehen am 27.05.2020"]}],"note":["Gesehen am 23.06.2021"],"title":[{"title_sort":"Prognostic impact of PD-L1 expression in pN1 NSCLC","subtitle":"a retrospective single-center analysis","title":"Prognostic impact of PD-L1 expression in pN1 NSCLC"}]} 
SRT |a EICHHORNFLPROGNOSTIC2320